Clinical Trials Browser

Breast Neoplasms, Colonic Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms, Radiation Injuries, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Cardiotoxicity

NCT06881940 2025-03-18

CARPTOX-BC

Phase NA Not yet recruiting

284 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

NCT05465031 2025-03-14

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Phase 4 Recruiting

600 enrolled

Breast

Breast Diseases, Breast Neoplasms, Heart Failure, Neoplasms, Second Primary, Cardiotoxicity

NCT05403736 2025-02-06

CARMA

Phase NA Completed

20 enrolled

BreastGastrointestinalThoracic

Breast Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Neoplasms, Cardiotoxicity

NCT06622954 2024-10-02

PROTECT-COR

Phase NA Recruiting

32 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

NCT06595316 2024-09-19

Exercise for Ameliorating Chemotherapy Cardiotoxicity

Phase NA Not yet recruiting

30 enrolled

Breast

Breast Neoplasms, Motor Activity, Cardiotoxicity

NCT03748550 2024-08-21

EXACT2

Phase NA Active not recruiting

7 enrolled

Breast

Breast Neoplasms, Cardiovascular Diseases, Cardiotoxicity

NCT05851053 2024-05-29

BLOC-II

Recruiting

455 enrolled

Breast

Breast Neoplasms, Heart Failure, Ventricular Dysfunction, Cardiotoxicity

NCT05467111 2024-04-11

CardioProtEx

Phase NA Unknown

40 enrolled

Breast

Breast Neoplasms, Motor Activity, Cardiotoxicity

NCT04896242 2024-04-04

Multimodal Assesment of Acute Cardiac Toxicity Induced by Thoracic Radiotherapy in Cancer Patients

Completed

47 enrolled

BreastGastrointestinalThoracic

Breast Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Neoplasms, Cardiotoxicity

NCT06341842 2024-04-02

PROTECT

Phase 2 Unknown

316 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

NCT06340516 2024-04-01

NT-proBNP to Assess Trastuzumab-induced Cardiotoxicity

Phase NA Recruiting

700 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

NCT06282796 2024-02-28

Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

Recruiting

600 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

NCT02605512 2023-11-08

BACCARAT

Phase NA Completed

118 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

NCT02881203 2023-07-27

BRAVEHeart

Phase NA Completed

45 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

NCT05921279 2023-07-25

UCARE

Recruiting

100 enrolled

Breast

Breast Neoplasms, Heart Failure, Cardiomyopathies, Neoplasms, Cardiotoxicity

NCT05960214 2023-07-25

AQUA

Completed

26 enrolled

Breast

Breast Neoplasms, Heart Diseases, beta-Thalassemia, Cardiotoxicity

NCT05927246 2023-07-03

RADAF

Completed

400 enrolled

BreastThoracic

Atrial Fibrillation, Breast Neoplasms, Lung Neoplasms, Cardiotoxicity

NCT05892146 2023-06-07

Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction

Phase NA Unknown

100 enrolled

BreastLymphoid

Breast Neoplasms, Heart Failure, Lymphoma, Cardiotoxicity

NCT01719562 2023-05-19

MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum

Phase NA Completed

28 enrolled 17 charts

Breast

Breast Neoplasms, Neoplasms, Cardiotoxicity

Clinical Trials

A Study of Blood Pressure Control During Cancer Treatment

C-BREAST-01

HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy

G-COR

ML-CardioTox

CARE-BREAST

Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Companion Study

Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature

SCARA-B

Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity

Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy

BE-FITTER

BRAVE-HEART

OTT 15-05

ROSUBREAST

ATOPE

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

CCT2

CCTGuide Pilot

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity

Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients

PROACT

Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients

NTproBNP-Guide

The Effects of Two Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic Chemotherapies

TRUST-ACE

CorTox

JUSTIFY

Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses

CARTIER

CARPTOX-BC

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

CARMA

PROTECT-COR

Exercise for Ameliorating Chemotherapy Cardiotoxicity

EXACT2

BLOC-II

CardioProtEx

Multimodal Assesment of Acute Cardiac Toxicity Induced by Thoracic Radiotherapy in Cancer Patients

PROTECT

NT-proBNP to Assess Trastuzumab-induced Cardiotoxicity

Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

BACCARAT

BRAVEHeart

UCARE

AQUA

RADAF

Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction

MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum